Research Team Creates Statistical Model To Predict COVID-19 Resistance

Study Shows FDA-Approved TB Regimen May Not Work Against the Deadliest Form of TB Due to Multidrug-Resistant Strains

Key Change in Genetics of SARS-CoV-2 Evolved to Counter Weakness Caused by the Virus’ Initial Mutation that Enabled Its Spread

Study Shows Paxlovid Can Safely Be Used to Reduce Risk of Severe COVID in People Who Are Pregnant

Johns Hopkins Medicine Awarded $10 Million to Optimize Antibiotic Therapy for Bacterial Infections

Johns Hopkins Experts Available for Interviews on This Year’s Flu Virus and Vaccine

Promising Anti-Cancer Drug Also May Function as COVID-19 Antiviral Therapy

Significant Boost in Rates of Type 2 Diabetes Among Children During COVID-19 Pandemic

Study Finds Genetic Method for Identifying Hundreds of Disease Agents ‘Promising’

Johns Hopkins Medicine-Led Consortium to Receive Up to $200 Million to Fight TB Globally